Author:
Cerván Ana,Hirschfeld Miguel,Rodriguez Miguel,Guerado Enrique
Publisher
Springer International Publishing
Reference53 articles.
1. Agalar C, Usubutun S, Turkyilmaz R (1999) Ciprofloxacin and rifampicin versus doxycycline and rifampicin in the treatment of brucellosis. Eur J Clin Microbiol Infect Dis 18:535–538
2. Ariza J, Bosilkovski M, Cascio A, Colmenero JD, Corbel MJ, Falagas ME, Memish ZA, Roushan MR, Rubinstein E, Sipsas NV, Solera J, Young EJ, Pappas G (2007) Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations. PLoS Med 4, e317
3. Ariza J, Gudiol F, Valverde J, Pallarés R, Fernández-Viladrich P, Rufí G, Espadaler L, Fernández-Nogues F (1985) Comparative trial of rifampin-doxycycline versus tetracycline-streptomycin in the therapy of human brucellosis. Antimicrob Agents Chemother 28:548–551
4. Bordur H, Erbay A, Akinci E, Colpan A, Cevik MA, Balaban N (2003) Neurobrucellosis in an endemic area of brucellosis. Scand J Infect Dis 5:94–97
5. Bossi P, Tegnell A, Baka A, Van Loock F, Hendriks J, Werner A, Maidhof H, Gouvras G, Task Force on Biological and Chemical Agent Threats, Public Health Directorate, European Commission, Luxembourg (2004) Bichat guidelines for the clinical management of brucellosis and bioterrorism-related brucellosis. Euro Surveill 9:1–5